Dr. Singh Nominated for “Best Clinical Paper” at the NASS 28th Annual Meeting

Dr. Singh Nominated for “Best Clinical Paper” at the NASS 28th Annual Meeting

Dr. Kern Singh Co-Director of the Minimally Invasive Spine Institute, has conducted several studies about the bone morphogenetic protein (BMP). His national database work was recently nominated for “Best Clinical Paper” at the North American Spine Society (NASS) 28th Annual Meeting in October. With his extensive experience and knowledge on the subject of BMP, Dr. Singh was asked to provide his professional insight in an Orthopedics This Week article.

Share this post